These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 29191234)

  • 1. Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.
    Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
    Radiat Oncol; 2017 Dec; 12(1):192. PubMed ID: 29191234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis.
    Katayama N; Takemoto M; Takamoto A; Ihara H; Katsui K; Ebara S; Nasu Y; Kanazawa S
    J Radiat Res; 2016 Jul; 57(4):393-9. PubMed ID: 26976125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapy.
    Ishiyama H; Satoh T; Yorozu A; Saito S; Kataoka M; Hashine K; Nakamura R; Tanji S; Masui K; Okihara K; Ohashi T; Momma T; Aoki M; Miki K; Kato M; Morita M; Katayama N; Nasu Y; Kawanaka T; Fukumori T; Ito F; Shiroki R; Baba Y; Inadome A; Yoshioka Y; Takayama H; Hayakawa K
    J Radiat Res; 2016 Jan; 57(1):68-74. PubMed ID: 26494116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.
    Yan C; Huq MS; Heron DE; Beriwal S; Wynn RB
    Brachytherapy; 2019; 18(3):338-347. PubMed ID: 30655047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intraoperatively built custom linked seeds versus loose seed gun applicator technique using real-time intraoperative planning for permanent prostate brachytherapy.
    Zauls AJ; Ashenafi MS; Onicescu G; Clarke HS; Marshall DT
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1010-6. PubMed ID: 20888132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is intraoperative nomogram-based overplanning of prostate implants necessary?
    D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.
    Nakano M; Yorozu A; Saito S; Sugawara A; Maruo S; Kojima S; Kikuchi T; Fukushima M; Dokiya T; Yamanaka H
    Radiat Oncol; 2015 Nov; 10():228. PubMed ID: 26577301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy.
    Inada M; Yokokawa M; Minami T; Nakamatsu K; Nishimura Y
    J Contemp Brachytherapy; 2017 Oct; 9(5):410-417. PubMed ID: 29204161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans.
    Major T; Agoston P; Fröhlich G; Baricza K; Szabo Z; Jorgo K; Herein A; Polgar C
    Phys Med; 2014 Dec; 30(8):909-13. PubMed ID: 25175151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric outcomes of preoperative treatment planning with intraoperative optimization using stranded seeds in prostate brachytherapy.
    Lee JJB; Lee E; Choi WH; Kim J; Chang KH; Kim DW; Shin HB; Kim TH; Byun HK; Cho J
    PLoS One; 2022; 17(3):e0265143. PubMed ID: 35353847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of post-implant dosimetrics between intraoperatively built custom-linked seeds and loose seeds by sector analysis at 24 hours and 1 month for localized prostate cancer.
    Okazaki E; Kuratsukuri K; Nishikawa T; Tanaka T; Sakagami M; Shibuya K
    J Contemp Brachytherapy; 2020 Aug; 12(4):317-326. PubMed ID: 33293970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective quasi-randomized comparison of intraoperatively built custom-linked seeds versus loose seeds for prostate brachytherapy.
    Ishiyama H; Satoh T; Kawakami S; Tsumura H; Komori S; Tabata K; Sekiguchi A; Takahashi R; Soda I; Takenaka K; Iwamura M; Hayakawa K
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):134-9. PubMed ID: 24986744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.
    Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
    Jpn J Radiol; 2016 Nov; 34(11):718-723. PubMed ID: 27631882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.
    Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Polgár C; Major T
    Strahlenther Onkol; 2010 Jul; 186(7):388-95. PubMed ID: 20582396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
    Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
    Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density.
    Thomas CW; Kruk A; McGahan CE; Spadinger I; Morris WJ
    Radiother Oncol; 2007 Apr; 83(1):18-24. PubMed ID: 17368844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
    McLaughlin P; Narayana V; Pan C; Berri S; Troyer S; Herman J; Evans V; Roberson P
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):144-50. PubMed ID: 16243441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
    Li XA; Wang JZ; Stewart RD; DiBiase SJ
    Phys Med Biol; 2003 Sep; 48(17):2753-65. PubMed ID: 14516099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.